FDA IOM: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease Thomas Sullivan May 26, 2010 0 In 2008, the Food and Drug Administration (FDA) asked the Institute of Medicine (IOM) to conduct a study on the evaluation…
